• Home
  • Technology
  • Pipeline
  • Partnership
  • Career
  • Team
  • Contact

Our Technology


⦁ We use proprietary designed primers for phage library construction with PBMC samples from immunized Alpaca.


⦁ We own self-designed, low liability, humanized, novel synthetic single-domain (VHH) antibody library, with diversity > 3x1010. ​


⦁ We use cutting-edge technology and state-of-the-art screening platform for VHH antibody discovery, using MOA mimic in vitro and ex vivo assays to evaluate and select functional antibodies.



Copyright © 2020 Bright Biologics LLC - All Rights Reserved.